Practicing population based care is a central focus of the Affordable Care Act and a key component of implementing health reform. Wellness and Prevention, Accountable Care Organizations, Patient Centered Medical Homes, Comparative Effectiveness Research, and Patient Engagement have become common terms in the healthcare lexicon. Aimed at students and practitioners in health care settings, the Second Edition of Population Health: Creating a Culture of Wellness, conveys the key concepts of concepts of population health management and strategies for creating a culture of health and wellness in the context of health care reform.

Cracking Health Costs reveals the best ways for companies and small businesses to fight back, right now, against rising health care costs. This book proposes multiple, practical steps that you can take to control costs and increase the effectiveness of the health benefit.

If you work for a large company or a government agency, you are probably one of over 50 million Americans subject to a workplace wellness program. This number grows daily, and if you work for a smaller firm, workplace wellness is headed your way soon. It’s hard to believe that something as pure sounding as “workplace wellness” could be bad for you, but conventional workplace wellness programs are proof that nightmares are real.

Conflicts of interest, misrepresentation of clinical trials, hospital price-fixing, and massive expenditures for procedures of dubious efficacy--these and other critical flaws leave little doubt that the current U.S. health-care system is in need of an overhaul. In this essential guide, preeminent physician Nortin Hadler urges American health-care consumers to take time to understand the existing system and to visualize what the outcome of successful reform might look like.

How We Do Harm exposes the underbelly of healthcare today―the overtreatment of the rich, the under treatment of the poor, the financial conflicts of interest that determine the care that physicians' provide, insurance companies that don't demand the best (or even the least expensive) care, and pharmaceutical companies concerned with selling drugs, regardless of whether they improve health or do harm.